[Increase of body resistance to infection and a stimulation of regenerative process under the combined effect of prodigiozan and methyluracil].
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001861:Bone Regeneration / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D008264:Macrophages / Q000187:drug effects; D008779:Methylthiouracil / Q000627:therapeutic use*; D051379:Mice; D010587:Phagocytosis / Q000187:drug effects; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000627:therapeutic use*; D012706:Serratia marcescens; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013268:Stimulation, Chemical; D013997:Time Factors; D014068:Tonsillectomy; D014498:Uracil / Q000008:administration & dosage; D014945:Wound Healing / Q000187:drug effects*; D014946:Wound Infection / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D011135:Polysaccharides, Bacterial; D014498:Uracil; D008779:Methylthiouracil
Usilenie soprotivilîaemosti organizma k infektsii i stimuliatsiia regeneratornogo preotsessa pri sochetannom primenenii prodigiozana i metiluratsila.